Associate Director of Machine Learning in Epidemiology and Patient Dat…
Valo HealthSalary not specified
- Full Time
- Senior (5 to 8 years)
About Valo Health
Valo Health focuses on drug discovery and development in the biopharmaceutical sector, utilizing advanced technology to create new drugs and therapies. The company employs its proprietary Opal Computational platform, which integrates machine learning, tissue biology, and patient data to streamline the drug discovery process. This platform allows Valo Health to identify potential drug candidates more quickly and accurately than traditional methods. Valo Health differentiates itself from competitors by combining technology with life sciences, fostering a collaborative culture that addresses significant challenges in drug development. The company's goal is to improve health outcomes for patients worldwide by delivering effective solutions through partnerships with pharmaceutical companies and research institutions.
Boston, MassachusettsHeadquarters
2019Year Founded
$474.2MTotal Funding
LATE_VCCompany Stage
AI & Machine Learning, BiotechnologyIndustries
51-200Employees
Risks
Leadership changes may impact Valo's strategic direction and decision-making.
Heavy reliance on Novo Nordisk partnership poses financial risks if expectations aren't met.
Intensifying competition in AI-driven drug discovery could challenge Valo's market position.
Differentiation
Valo Health integrates AI and human-centric data for drug discovery and development.
The Opal Computational Platform offers an end-to-end solution for drug discovery.
Valo's approach combines machine learning, tissue biology, and patient data for precision therapeutics.
Upsides
Valo's partnership with Novo Nordisk could yield up to $4.6 billion in milestone payments.
The growing market for AI-driven drug discovery platforms supports Valo's business model.
Strategic partnerships with pharmaceutical companies enhance Valo's revenue and market reach.
Funding
Total raised$474.20 M
Latest valuation$950.00 M
StageLATE_VC
LATE VC
10/31/2021$1
$950.00 MSPAC PRIVATE PLACEMENT
5/31/2021$168
$2.80 BSPAC IPO
5/31/2021$300
$2.80 BEARLY VC
11/30/2020$3
$15.00 MDEBT
11/30/2020$40
SERIES A
6/30/2019$95
$475.00 MSEED
10/31/2018$55
$275.00 M